Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
CAR T-cell therapy comes of age: Introductory editorial for the special issue63
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial62
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies54
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation49
Clinical applications of circulating tumor DNA in Hodgkin lymphoma46
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?45
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia45
Epidemiology and etiology of diffuse large B-cell lymphoma43
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1939
How to set up a clinical research center in Brazil, as an example of a middle-income country38
Somatic mutations in “benign” blood diseases31
Lessons learned from the Eµ-TCL1 mouse model of CLL29
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence26
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services22
The role of viruses in HIV-associated lymphomas21
Antibody and immunotherapy in diffuse large B-cell lymphoma20
Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future19
TET2 mutation as prototypic clonal hematopoiesis lesion19
Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?18
0.032572031021118